Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$22,144,286
in 6 filings, $22.1M under 10b5-1 plans

Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-10 LaBarre Michael J. SVP, Chief Technical Officer Grant or award · Option to Purchase Common Stock +69,174 69,174
2020-02-10 LaBarre Michael J. SVP, Chief Technical Officer Grant or award · Restricted Stock Units +32,533 32,533
2020-02-10 Stelzer Laurie SVP, Chief Financial Officer Grant or award · Option to Purchase Common Stock +69,174 69,174
2020-02-10 Stelzer Laurie SVP, Chief Financial Officer Grant or award · Restricted Stock Units +32,533 32,533
2020-02-10 Torley Helen President and CEO Grant or award · Option to Purchase Common Stock +266,051 266,051
2020-02-10 Torley Helen President and CEO Grant or award · Restricted Stock Units +125,126 125,126
2020-02-03 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion +11,559 165,782
2020-02-03 LaBarre Michael J. SVP, Chief Technical Officer Shares withheld for taxes −4,289 $19.21 $82K 161,493
2020-02-03 LaBarre Michael J. SVP, Chief Technical Officer Exercise or conversion · Common Stock +11,559 0
2020-02-03 Stelzer Laurie SVP, Chief Financial Officer Exercise or conversion +23,119 105,081
2020-02-03 Stelzer Laurie SVP, Chief Financial Officer Shares withheld for taxes −8,275 $19.21 $159K 96,806
2020-02-03 Stelzer Laurie SVP, Chief Financial Officer Exercise or conversion · Restricted Stock Units −23,119 0
2020-02-03 Torley Helen President and CEO Exercise or conversion +55,487 459,567
2020-02-03 Torley Helen President and CEO Shares withheld for taxes −19,910 $19.21 $382K 439,657
2020-02-03 Torley Helen President and CEO Exercise or conversion · Restricted Stock Units −55,487 0
2019-10-01 Hickey Benjamin SVP, Chief Commerical Officer Exercise or conversion +20,216 20,216
2019-10-01 Hickey Benjamin SVP, Chief Commerical Officer Shares withheld for taxes −6,990 $15.46 $108K 13,226
2019-10-01 Hickey Benjamin SVP, Chief Commerical Officer Exercise or conversion · Restricted Stock Units −20,216 60,647
2019-08-03 Chondros Dimitrios SVP, Chief Medical Officer Sale −1,328 $16.70 $22K 38,584
2019-06-15 Stelzer Laurie SVP, Chief Financial Officer Exercise or conversion +6,875 85,370

Page 58 of 59 · 1,177 trades